In Wednesday trading, the SPDR S&P Biotech ETF outperformed other ETFs, rising approximately 0.7%. Notable contributors to this increase included Oruka Therapeutics, which surged by about 5.5%, and Arcutis Biotherapeutics, up 5%.
Conversely, the Sprott Silver Miners & Physical Silver ETF decreased by around 2.3%. Key underperformers in this category included Americas Gold and Silver, down approximately 2.8%, and Vizsla Silver, which fell by about 1.6%.
